Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms
Background and Objectives: Upper urinary tract infections (UTIs) that require in-patient care can be expensive. Comorbid conditions such as diabetes as well as UTI due to extended-spectrum beta-lactamase (ESBL) producing bacteria may affect costs. The quality of life of patients with this condition...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | CHRISMED Journal of Health and Research |
| Subjects: | |
| Online Access: | http://www.cjhr.org/article.asp?issn=2348-3334;year=2022;volume=9;issue=4;spage=223;epage=230;aulast=Daniel |
| _version_ | 1797824452564615168 |
|---|---|
| author | Ebenezer Daniel Bijesh Yadav Lakshmanan Jeyaseelan Malavika Babu Selvin Sundar Raj Mani Alice Joan Mathuram Sowmya Sathyendra Samuel George Hansdak Ramya Iyyadurai Rani Diana Sahni Thambu David Sudarsanam |
| author_facet | Ebenezer Daniel Bijesh Yadav Lakshmanan Jeyaseelan Malavika Babu Selvin Sundar Raj Mani Alice Joan Mathuram Sowmya Sathyendra Samuel George Hansdak Ramya Iyyadurai Rani Diana Sahni Thambu David Sudarsanam |
| author_sort | Ebenezer Daniel |
| collection | DOAJ |
| description | Background and Objectives: Upper urinary tract infections (UTIs) that require in-patient care can be expensive. Comorbid conditions such as diabetes as well as UTI due to extended-spectrum beta-lactamase (ESBL) producing bacteria may affect costs. The quality of life of patients with this condition has not been described. Methods: This was a cost of illness study that prospectively evaluated patients admitted with upper UTI to a medical ward in a tertiary care hospital. Direct medical and nonmedical costs, indirect costs were collected to make the total cost per admission. Quality of life was assessed using the World Health Organization Quality of Life-BREF score. We also compared costs between those with and without diabetes or ESBL infection. Results: Between March 2016 and July 2017, 92 eligible patients were included in the study. The average age was 55.8 years; two thirds were diabetics. The mean overall cost of a single admission for upper UTI was INR.88, 330.2 (1370.4 USD). This was INR.96, 193.0 (1492.6 USD) and INR.1, 03,154.9 (1600.4 USD) among those with diabetes mellitus and ESBL infection, respectively. The cost was higher among those with diabetes and ESBL than those without; this difference reached statistically significance for the ESBL group. The quality of life was affected in all domains; the psychological being most affected among diabetics and ESBL infected. Conclusions: The mean total cost of admission for an upper UTI in a tertiary care hospital in South India was INR 88,330 (1370.4 USD). This is higher if the patient has diabetes or ESBL organism causing the UTI. Quality of life is clearly reduced especially in the psychological domain. |
| first_indexed | 2024-03-13T10:39:12Z |
| format | Article |
| id | doaj.art-97468c1da48e4b78a09f81e2523f068e |
| institution | Directory Open Access Journal |
| issn | 2348-3334 2348-506X |
| language | English |
| last_indexed | 2024-03-13T10:39:12Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | CHRISMED Journal of Health and Research |
| spelling | doaj.art-97468c1da48e4b78a09f81e2523f068e2023-05-18T05:04:51ZengWolters Kluwer Medknow PublicationsCHRISMED Journal of Health and Research2348-33342348-506X2022-01-019422323010.4103/cjhr.cjhr_105_22Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organismsEbenezer DanielBijesh YadavLakshmanan JeyaseelanMalavika BabuSelvin Sundar Raj ManiAlice Joan MathuramSowmya SathyendraSamuel George HansdakRamya IyyaduraiRani Diana SahniThambu David SudarsanamBackground and Objectives: Upper urinary tract infections (UTIs) that require in-patient care can be expensive. Comorbid conditions such as diabetes as well as UTI due to extended-spectrum beta-lactamase (ESBL) producing bacteria may affect costs. The quality of life of patients with this condition has not been described. Methods: This was a cost of illness study that prospectively evaluated patients admitted with upper UTI to a medical ward in a tertiary care hospital. Direct medical and nonmedical costs, indirect costs were collected to make the total cost per admission. Quality of life was assessed using the World Health Organization Quality of Life-BREF score. We also compared costs between those with and without diabetes or ESBL infection. Results: Between March 2016 and July 2017, 92 eligible patients were included in the study. The average age was 55.8 years; two thirds were diabetics. The mean overall cost of a single admission for upper UTI was INR.88, 330.2 (1370.4 USD). This was INR.96, 193.0 (1492.6 USD) and INR.1, 03,154.9 (1600.4 USD) among those with diabetes mellitus and ESBL infection, respectively. The cost was higher among those with diabetes and ESBL than those without; this difference reached statistically significance for the ESBL group. The quality of life was affected in all domains; the psychological being most affected among diabetics and ESBL infected. Conclusions: The mean total cost of admission for an upper UTI in a tertiary care hospital in South India was INR 88,330 (1370.4 USD). This is higher if the patient has diabetes or ESBL organism causing the UTI. Quality of life is clearly reduced especially in the psychological domain.http://www.cjhr.org/article.asp?issn=2348-3334;year=2022;volume=9;issue=4;spage=223;epage=230;aulast=Danieldiabetes mellitusextended-spectrum beta-lactamasegenitourinary medicinehealth economicsquality of lifeurinary tract infections |
| spellingShingle | Ebenezer Daniel Bijesh Yadav Lakshmanan Jeyaseelan Malavika Babu Selvin Sundar Raj Mani Alice Joan Mathuram Sowmya Sathyendra Samuel George Hansdak Ramya Iyyadurai Rani Diana Sahni Thambu David Sudarsanam Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms CHRISMED Journal of Health and Research diabetes mellitus extended-spectrum beta-lactamase genitourinary medicine health economics quality of life urinary tract infections |
| title | Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms |
| title_full | Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms |
| title_fullStr | Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms |
| title_full_unstemmed | Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms |
| title_short | Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms |
| title_sort | cost of care and impact on quality of life of upper urinary tract infections in south india with a focus on diabetics and extended spectrum beta lactam producing organisms |
| topic | diabetes mellitus extended-spectrum beta-lactamase genitourinary medicine health economics quality of life urinary tract infections |
| url | http://www.cjhr.org/article.asp?issn=2348-3334;year=2022;volume=9;issue=4;spage=223;epage=230;aulast=Daniel |
| work_keys_str_mv | AT ebenezerdaniel costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT bijeshyadav costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT lakshmananjeyaseelan costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT malavikababu costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT selvinsundarrajmani costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT alicejoanmathuram costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT sowmyasathyendra costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT samuelgeorgehansdak costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT ramyaiyyadurai costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT ranidianasahni costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms AT thambudavidsudarsanam costofcareandimpactonqualityoflifeofupperurinarytractinfectionsinsouthindiawithafocusondiabeticsandextendedspectrumbetalactamproducingorganisms |